 | Alnylam to Webcast Presentations at Upcoming March Investor Conferences
finance.yahoo.com - February 25 at 7:40 AM |
| How biotech Alnylam plans to make a profit, and what stands in its way
finance.yahoo.com - February 24 at 7:23 AM |
 | Insider Selling: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) CEO Sells 34,765 Shares of Stock
www.americanbankingnews.com - February 21 at 5:29 PM |
| Alnylam to Webcast Presentation at 9th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 20 at 12:53 PM |
| Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - February 19 at 3:15 PM |
 | Alnylam completes enrollment in late-stage vutrisiran study
seekingalpha.com - February 18 at 12:46 PM |
 | Alnylam Completes Enrollment of HELIOS-A Phase 3 Study of Vutrisiran for the Treatment of hATTR Amyloidosis with Polyneuropathy
www.marketwatch.com - February 18 at 12:46 PM |
| Ionis Pharmaceuticals Looks Undervalued - Q4, FY Earnings Will Be Important
seekingalpha.com - February 16 at 10:39 PM |
| Head to Head Analysis: Alnylam Pharmaceuticals (NASDAQ:ALNY) and Orexigen Therapeutics (NASDAQ:OREXQ)
www.americanbankingnews.com - February 16 at 6:16 PM |
| Dyslipidemia Drugs Market - Rapid Growth at Deep Value Price | Merck, Pfizer, Sanofi
www.marketwatch.com - February 14 at 6:31 PM |
| RNAi for Therapeutic Market: Identifying key players and it 's most promising pipeline therapeutics
www.marketwatch.com - February 14 at 1:30 PM |
| Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Short Interest Up 8.6% in January
www.americanbankingnews.com - February 14 at 7:22 AM |
| Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Expected to Post Quarterly Sales of $93.23 Million
www.americanbankingnews.com - February 13 at 3:02 AM |
| Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) COO Yvonne Greenstreet Sells 6,250 Shares
www.americanbankingnews.com - February 11 at 7:04 PM |
| Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) COO Yvonne Greenstreet Sells 9,892 Shares
www.americanbankingnews.com - February 11 at 7:04 PM |
| Akshay Vaishnaw Sells 23,708 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Stock
www.americanbankingnews.com - February 11 at 7:04 PM |
| Insider Selling: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Director Sells 30,000 Shares of Stock
www.americanbankingnews.com - February 11 at 7:04 PM |
| Zacks: Brokerages Expect Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Will Announce Earnings of -$1.84 Per Share
www.americanbankingnews.com - February 11 at 6:55 PM |
 | Thinking about trading options or stock in Alnylam Pharmaceuticals, Bed Bath & Beyond, Microsoft, NVIDIA, or Sprint?
www.prnewswire.com - February 11 at 12:40 PM |
| Alnylam Pharmaceuticals (NASDAQ:ALNY) PT Raised to $75.00
www.americanbankingnews.com - February 11 at 9:59 AM |
| Alnylam Pharmaceuticals (NASDAQ:ALNY) Research Coverage Started at Evercore ISI
www.americanbankingnews.com - February 10 at 6:59 AM |
| Cowen Reiterates Buy Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)
www.americanbankingnews.com - February 9 at 9:44 PM |
| Alnylam Pharmaceuticals (NASDAQ:ALNY) Issues Quarterly Earnings Results, Misses Expectations By $0.22 EPS
www.americanbankingnews.com - February 7 at 7:03 PM |
| Alnylam's (ALNY) Q4 Earnings Miss Estimates, Sales Beat
finance.yahoo.com - February 7 at 12:50 PM |
| Alnylam's (ALNY) Q4 Earnings Miss Estimates, Sales Beat
finance.yahoo.com - February 7 at 12:50 PM |
| Alnylam Pharmaceuticals (NASDAQ:ALNY) PT Lowered to $148.00 at Morgan Stanley
www.americanbankingnews.com - February 7 at 10:43 AM |
| Alnylam Pharmaceuticals (NASDAQ:ALNY) Receives "Buy" Rating from Chardan Capital
www.americanbankingnews.com - February 7 at 8:31 AM |
| Alnylam Pharmaceuticals (NASDAQ:ALNY) Receives "Buy" Rating from Needham & Company LLC
www.americanbankingnews.com - February 7 at 8:08 AM |
| Edited Transcript of ALNY earnings conference call or presentation 6-Feb-20 1:30pm GMT
finance.yahoo.com - February 7 at 7:49 AM |
 | Alnylam Beats Revenue Estimates, but Misses on Earnings
www.fool.com - February 6 at 4:42 PM |
| Alnylam Pharmaceuticals EPS misses by $0.25, beats on revenue
seekingalpha.com - February 6 at 4:42 PM |
 | BRIEF-Alnylam Pharmaceuticals Reports Q4 Net Product Revenues Of $55.9 Mln
www.msn.com - February 6 at 11:42 AM |
 | Alnylam Pharma Posts Wider Loss In Q4 - Quick Facts
www.nasdaq.com - February 6 at 11:42 AM |
| Q4 sales of Alnylam's Onpattro up 361%
seekingalpha.com - February 6 at 11:42 AM |
| Alnylam Pharmaceuticals, Inc. 2019 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 6 at 11:42 AM |
| Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Period Activity
finance.yahoo.com - February 6 at 11:42 AM |
| Traders Purchase High Volume of Alnylam Pharmaceuticals Put Options (NASDAQ:ALNY)
www.americanbankingnews.com - February 6 at 6:44 AM |
| Alnylam Pharmaceuticals Q4 Earnings Preview
seekingalpha.com - February 5 at 5:37 PM |
| In the highest ranks of Mass. corporate leadership, women still scarce
finance.yahoo.com - February 5 at 5:37 PM |
| European advisory group backs Alnylam's givosiran for AHP
seekingalpha.com - January 31 at 9:11 AM |
| Alnylam Receives Positive CHMP Opinion for GIVLAARI™ (givosiran) for the Treatment of Acute Hepatic Porphyria in Adults and Adolescents
finance.yahoo.com - January 31 at 9:11 AM |
| Earnings Preview: Alnylam Pharmaceuticals (ALNY) Q4 Earnings Expected to Decline
finance.yahoo.com - January 30 at 5:12 PM |
| Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2019 Financial Results
finance.yahoo.com - January 27 at 5:38 PM |
| Noteworthy Friday Option Activity: ALNY, EHTH, PBYI
www.nasdaq.com - January 17 at 5:17 PM |
| Are Investors Undervaluing Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) By 46%?
finance.yahoo.com - January 16 at 8:40 AM |
 | Alexion pushes 'high-risk, high-reward' ALS strategy amid competitive pressure
www.bizjournals.com - January 15 at 1:13 PM |
| Alnylam Pharmaceuticals (ALNY) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 14 at 5:11 PM |
| Alnylam Pharmaceuticals Beats Again, But The Bar Keeps Moving Higher
seekingalpha.com - January 14 at 2:01 PM |
| Drugmakers getting creative over ways to pay for pricey meds
seekingalpha.com - January 13 at 3:49 PM |
| Alnylam Provides Preliminary Q4 Sales for Onpattro & Givlaari
www.nasdaq.com - January 13 at 3:49 PM |
